Recall Z-1440-2017— Becton Dickinson & Company

Name: FDA recall Z-1440-2017
Creator: U.S. Food and Drug Administration
Published: 2016-12-20

Class II · Terminated

Class II FDA medical device recall by Becton Dickinson & Company, initiated 2016-12-20, terminated 2018-04-20. It names one FDA 510(k) clearance: K161170. Product: Eclipse Hypodermic Needle. Reason: BD is initiating a Product Advisory for the Eclipse Hypodermic Needle because of safety complaints covering disengagement and needlestick injuries..

Recalling firm: Becton Dickinson & Company
Classification: Class II
Status: Terminated
Initiated: 2016-12-20
Terminated: 2018-04-20
Firm location: Franklin Lakes, NJ, United States

510(k) clearances named in this recall

1 on FDA's record

K161170 — BD Eclipse Hypodermic NeedleBecton, Dickinson and Company·cleared 2016-05-27

K-numbers as listed on FDA's Recall Enterprise System record for this event (openFDA device/recall k_numbers). The recall may also cover devices cleared under other submissions not named here.

Product description

Eclipse Hypodermic Needle

Reason for recall

BD is initiating a Product Advisory for the Eclipse Hypodermic Needle because of safety complaints covering disengagement and needlestick injuries.

Data sourced from openFDA. This site is unofficial and independent of the FDA.